Literature DB >> 9018086

Induction of iNOS mRNA by interferon-gamma in epithelial cells is associated with growth arrest and differentiation.

I Arany1, M M Brysk, H Brysk, S K Tyring.   

Abstract

Induction of inducible nitric oxide synthase (iNOS) mRNA by interferon-gamma (IFNgamma) is well established in various cell types. We observed earlier that this induction is differentiation-dependent in human keratinocytes. Since IFNgamma-mediated growth arrest and differentiation are separable but interrelated processes in keratinocytes, iNOS might play a role in their regulation. We conducted a series of in vitro experiments on normal and transformed epithelial cells with different tissue origins. We found that immortalization and transformation can influence the IFNgamma-mediated iNOS inducibility, but this process is tissue-specific as the induction correlates with the ability of the cells to differentiate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9018086     DOI: 10.1016/s0304-3835(96)04476-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.

Authors:  Sanjoy Roychowdhury; Craig K Svensson
Journal:  AAPS J       Date:  2005-12-09       Impact factor: 4.009

Review 2.  Regulatory Role of Nitric Oxide in Cutaneous Inflammation.

Authors:  Mao-Qiang Man; Joan S Wakefield; Theodora M Mauro; Peter M Elias
Journal:  Inflammation       Date:  2022-01-30       Impact factor: 4.092

Review 3.  Role of nitric oxide in regulating epidermal permeability barrier function.

Authors:  Mao-Qiang Man; Joan S Wakefield; Theodora M Mauro; Peter M Elias
Journal:  Exp Dermatol       Date:  2021-11-01       Impact factor: 3.960

4.  Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation.

Authors:  T Fazekas; P Eickhoff; A Lawitschka; B Knotek; U Pötschger; C Peters
Journal:  Eur J Pediatr       Date:  2012-02-16       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.